Welltower (NYSE:WELL) Given “Neutral” Rating at JPMorgan Chase

JPMorgan Chase reiterated their neutral rating on shares of Welltower (NYSE:WELL) in a research report sent to investors on Friday, March 16th. JPMorgan Chase currently has a $67.00 price objective on the real estate investment trust’s stock, down from their previous price objective of $71.00.

Several other research firms have also weighed in on WELL. SunTrust Banks set a $66.00 price objective on shares of Welltower and gave the stock a hold rating in a report on Monday, January 22nd. TheStreet lowered shares of Welltower from a b- rating to a c+ rating in a report on Thursday, February 8th. Royal Bank of Canada set a $62.00 price target on shares of Welltower and gave the company a hold rating in a report on Monday, February 26th. Stephens set a $70.00 price target on shares of Welltower and gave the company a buy rating in a report on Friday, January 12th. Finally, Bank of America lowered their price target on shares of Welltower from $67.00 to $58.00 and set a neutral rating for the company in a report on Thursday, March 8th. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of Hold and a consensus target price of $64.77.

How to Become a New Pot Stock Millionaire

WELL traded up $0.28 during midday trading on Friday, reaching $55.01. 2,814,139 shares of the company’s stock were exchanged, compared to its average volume of 2,457,215. The stock has a market cap of $20,445.51, a price-to-earnings ratio of 13.07, a P/E/G ratio of 2.33 and a beta of 0.20. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.83. Welltower has a one year low of $51.63 and a one year high of $78.17.

Welltower (NYSE:WELL) last announced its quarterly earnings results on Thursday, February 22nd. The real estate investment trust reported $1.02 EPS for the quarter, missing analysts’ consensus estimates of $1.04 by ($0.02). The business had revenue of $1.10 billion for the quarter, compared to the consensus estimate of $1.09 billion. Welltower had a return on equity of 4.35% and a net margin of 12.13%. The firm’s revenue for the quarter was up 2.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.91 EPS. equities research analysts expect that Welltower will post 4.03 EPS for the current fiscal year.

In related news, Director Gary Whitelaw acquired 1,862 shares of the business’s stock in a transaction that occurred on Monday, February 26th. The shares were acquired at an average cost of $53.61 per share, with a total value of $99,821.82. Following the transaction, the director now owns 5,843 shares of the company’s stock, valued at approximately $313,243.23. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Kenneth J. Bacon acquired 600 shares of the business’s stock in a transaction that occurred on Thursday, March 15th. The stock was bought at an average cost of $53.63 per share, for a total transaction of $32,178.00. The disclosure for this purchase can be found here. Company insiders own 0.17% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Welltower (NYSE:WELL) Given “Neutral” Rating at JPMorgan Chase” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another site, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The legal version of this story can be viewed at https://www.dispatchtribunal.com/2018/04/08/welltowers-well-neutral-rating-reaffirmed-at-jpmorgan-chase-co.html.

About Welltower

Welltower Inc (NYSE:HCN), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.

Analyst Recommendations for Welltower (NYSE:WELL)

Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply